Abbott and Europroteome form breast cancer test deal
This article was originally published in Clinica
Executive Summary
Abbott Laboratories has linked up with German firm Europroteome in a pact to discover and develop early breast cancer in vitro diagnostic tests for use on Abbott's automated instrument systems. The programme aims to identify novel markers for breast cancer diagnosis and potential screening.